title: 'Les liaisons dangereuses': Hepatitis C, Rituximab and B-cell non-Hodgkin's lymphomas.
abstract: Rituximab has provided a revolutionary contribution to the treatment of B-cell non-Hodgkin's lymphomas (NHL). A high prevalence of hepatitis C virus (HCV) infection has been described in B-cell NHL patients. Cases of liver dysfunction in HCV-positive patients have been reported with Rituximab-containing regimens. In this paper we review the recent data regarding the effects of Rituximab in NHL patients with HCV infection. We also added a section devoted to improving communication between oncohaematologists and hepatologists. Furthermore, we propose a common methodological ground to study hepatic toxicity emerging during chemotherapy.
authors.affiliation: Massimo Marignani, Michela di Fonzo, Paola Begini, Elia Gigante, Ilaria Deli, Sara Gallina, Emanuela de Santis, Gianfranco Delle Fave, Department of Digestive and Liver Disease, School of Medicine and Psychology University "Sapienza", Azienda Ospedaliera S. Andrea, Via Grottarossa, 1035-1039, 00189 Rome, Italy.
authors.forename: Massimo
authors.initials: M
authors.lastname: Marignani
authors.forename: Michela di
authors.initials: Md
authors.lastname: Fonzo
authors.forename: Paola
authors.initials: P
authors.lastname: Begini
authors.forename: Elia
authors.initials: E
authors.lastname: Gigante
authors.forename: Ilaria
authors.initials: I
authors.lastname: Deli
authors.forename: Adriano M
authors.initials: AM
authors.lastname: Pellicelli
authors.forename: Sara
authors.initials: S
authors.lastname: Gallina
authors.forename: Emanuela
authors.initials: E
authors.lastname: de Santis
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Delle Fave
authors.forename: M Christina
authors.initials: MC
authors.lastname: Cox